Complete Revascularization and Angina-Related Health Status in the ISCHEMIA Trial

Kreton Mavromatis1, Philip G Jones2, Ziad A Ali3

  • 1Emory University, Atlanta VA Healthcare System, Atlanta, Georgia, USA.

Insights

Complete revascularization (CR) significantly improves health status in chronic coronary disease (CCD) patients, especially those with frequent angina. Both anatomic and functional CR offer comparable quality of life benefits compared to incomplete revascularization or conservative management.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Health Outcomes Research

Background:

  • The impact of complete revascularization (CR) on health status in chronic coronary disease (CCD) remains understudied.
  • Existing research lacks comprehensive data on CR's effect on symptoms, function, and quality of life.

Purpose of the Study:

  • To evaluate the impact of CR versus incomplete revascularization (ICR) on health status in CCD patients.
  • To compare the predicted impact of achieving CR in all invasive strategy patients versus conservative management.

Main Methods:

  • Analysis of data from the ISCHEMIA trial, comparing invasive (INV) versus conservative (CON) management.
  • Multivariable regression and propensity-weighted modeling to assess health status at 12 months post-intervention.
  • Independent core laboratory assessment of CR and incomplete revascularization (ICR).

Main Results:

  • Complete revascularization (CR) was achieved in 43.3% (anatomic) and 57.8% (functional) of invasive patients.
  • CR was associated with improved angina frequency compared to ICR.
  • Modeled CR and ICR in all invasive patients showed greater health status improvements than conservative management, with CR showing superior outcomes, particularly for patients with baseline frequent angina.

Conclusions:

  • Complete revascularization (CR) improves health status in chronic coronary disease (CCD) patients more than incomplete revascularization (ICR) or conservative (CON) management.
  • Benefits of CR are most significant in patients experiencing frequent angina.
  • Anatomic and functional CR yield comparable improvements in quality of life.
Abstract

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
11
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
18
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
8
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
10
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
11